Cargando…
Glucocorticoid Induced Cerebellar Toxicity in the Developing Neonate: Implications for Glucocorticoid Therapy during Bronchopulmonary Dysplasia
Prematurely born infants commonly suffer respiratory dysfunction due to the immature state of their lungs. As a result, clinicians often administer glucocorticoid (GC) therapy to accelerate lung maturation and reduce inflammation. Unfortunately, several studies have found GC therapy can also produce...
Autor principal: | Noguchi, Kevin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910303/ https://www.ncbi.nlm.nih.gov/pubmed/24501683 http://dx.doi.org/10.3390/cells3010036 |
Ejemplares similares
-
Comparative Transcriptional Analysis of Patient Responders Versus Non-Responders to Glucocorticoid Treatment for Bronchopulmonary Dysplasia
por: Shi, Victoria J, et al.
Publicado: (2021) -
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
por: McDowell, P. Jane, et al.
Publicado: (2022) -
Progressive Metabolic Abnormalities Associated with the Development of Neonatal Bronchopulmonary Dysplasia
por: Ye, Chengyin, et al.
Publicado: (2022) -
Long-term Effects of Multiple Glucocorticoid Exposures in Neonatal Mice
por: Maloney, Susan E., et al.
Publicado: (2011) -
Circulating Fibrocytes Are Increased in Neonates with Bronchopulmonary Dysplasia
por: Li, Chun, et al.
Publicado: (2016)